Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: "The article states that the costs are "generally close to $45,000." The news story notes in a sentence that hip replacement has a success rate of more than 90%, and defines "success" as "relatively pain-free mobility." The article also clearly states why this new device was developed to provide longer lifetime use prior to device failure. It quantifies this benefit vaguely, saying the device is ""much more durable"" and lasts ""much longer."" The news story focuses on one main harmsqueaking in hip implants made of ceramicand provides estimates of its prevalence. A spokesperson for the hip maker points out that hip replacement has other potential risks as well, including infection, dislocation, and leg-length discrepancy. The news story makes it fairly clear that the research it is citing is from cohort studies. The first mention of the prevalence of squeaking in ceramic hip implants appears to cite the highest known estimate7% of ceramic implants in one study of 143 patients. Only later do readers discover that other studies suggest the prevalence of the problem may be much smaller, from 3% (in a study of 1500 people) to less than 1%. This is not disease mongering, but it could cause some people to fear ceramic hip implants more than may be justified. In addition, the Times article says no squeaking occurred in patients with metal and plastic implants. But a recent 2007 review in the Journal of Bone & Joint Surgery (JBJS) reported that squeaking in similar implants made out of metal and plastic occurred in 4% of patients. (JBJS 2007;89:1874-85) If the JBJS review is accurate, the news story would be misleading. Unfortunately, the JBJS failed to support its own contention with a complete reference. The story cites 4 patients, 4 surgeons, a spokesperson for implant maker Stryker, and a lawyer representing aggrieved patients. All in all, they provide a balance of viewpoints. The story mentions a conflict of interest for one surgeon. It appears that 2 of the patients are clients of the lawyer. The story points out that the alternatives to a ceramic total hip replacement include hip replacements with implants made from metal and plastic. It doesn't mention whether there are nonsurgical alternatives to hip replacement, but this is beyond the scope of the story. The story does not explicitly state that ceramic hip replacements are approved by the FDA, but with "tens of thousands" implanted, it's clear that surgeons' adoption of the devices is widespread. The FDA's warning to implant maker Stryker about squeaking suggests the devices may not be perfect, but are approved. The story notes that Stryker introduced ceramic hip implants into the U.S. in 2003. The story cites several sources and does not appear to rely solely or largely on a news release."

Output: That Must Be Bob. I Hear His New Hip Squeaking.

Input: Consider Input: In a study in the medical journal The Lancet, they said the patients, with strains of TB known as extensively-drug resistant (XDR) and totally drug resistant (TDR) TB, have exhausted all available treatment options and are sent home. "These patients can survive for months or even years and are contributing to the community-based spread of XDR-TB," said Keertan Dheda, who led the study at the University of Cape Town's department of medicine. Tuberculosis infects the lungs and can spread through coughing and sneezing. In recent years, drug-resistant strains have spread around the world, batting off standard antibiotics and posing an increasingly urgent public health threat. The World Health Organization (WHO) estimates that in Eastern Europe, Asia and South Africa, 450,000 people have MDR-TB, and around half of these will fail to respond to existing treatments. Dheda's team followed 107 patients with XDR-TB from three provinces in South Africa between March 2008 and August 2012 to establish their fate. They also took samples from 56 patients and tested them to find out which and how many of 10 first- and second-line anti-TB drugs they were susceptible to. Despite being treated intensively with an average of eight anti-tuberculosis drugs, many of the patients fared poorly, with high rates of treatment failure and death. Five years after treatment initiation, only 12 of the patients had favorable outcomes and 74 percent had died. The researchers found that almost two-thirds of the tested patients had resistance to at least eight drugs, and there was one case of totally drug-resistant TB that was not susceptible to any of the 10 drugs tested. More worrisome, Dheda said, was that of the XDR-TB patients discharged into the general community, some 42 percent had failed to get better on treatment and were testing positive for active TB, and of these almost a third were at high risk of transmitting the disease. The patients also survived in the community for an average of 20 months - plenty of time to infect others. When people with lung TB cough, sneeze or spit, they propel the TB germs into the air. Another person needs to inhale only a few of these germs to become infected. "Alarmingly, we have shown for the first time that... treatment failure and discharge of such patients into the wider community is occurring systematically on a country-wide level in South Africa," Dheda said in a statement about the findings. In one case where the researchers followed a genetic trail of transmission, they found that a patient with XDR-TB who was discharged after failing treatment went on to infect his brother, who also eventually died. Dheda said the reason many TB patients are being sent away from hospitals appeared to be lack of bed space in designated tuberculosis hospitals. "And alternative long-term residential and palliative care facilities are scarce." Commenting on the findings in The Lancet, Max O'Donnell from New York's Albert Einstein College of Medicine in the United States said they should serve as an "urgent alarm". "MDR-TB (multi-drug-resistant TB) in all its forms is an out-of-control problem with potentially vast and devastating consequences for global public health," he wrote. "The situation regarding MDR and XDR-TB is bleak."

Output: South Africa risks spreading totally drug-resistant TB: study.

Input: Consider Input: Faith Gardens in Sun Prairie was also fined $4,200, the Wisconsin State Journal reported . Alice McGaw was discovered dead outside the facility in December when temperatures were below 10 degrees. McGaw had been transferred to the facility in October after she rolled her wheelchair out of another assisted living facility and was almost hit by a car. "The family decided to be pro-active and look for a smaller facility, and with winter coming they wanted a more secure environment," according to a state Department of Health Services inspection report released Monday. Faith Gardens didn't have a front-door alarm, left an inside door propped open and failed to check on the 84-year-old frequently enough, the report said. McGaw's care plan also required she wear an alarm bracelet, but the facility didn't employ the bracelet system, the report found. The facility cannot accept new residents until the violations are corrected. The only sanction more serious is having a license revoked. Faith Gardens officials didn't immediately respond to the newspaper's request for comment. There are huge regulation gaps when it comes to assisted living facilities, according to a U.S. Government Accountability Office report released Monday. Many states don't have information about abuse, neglect or unexplained deaths at facilities, the agency said. Wisconsin has nearly 4,200 assisted living facilities, which can accommodate more than 59,000 people. ___ Information from: Wisconsin State Journal, http://www.madison.com/wsj
Output: Wisconsin sanctions assisted living facility after death.